CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 28,000 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 2,004 shares at $20.00 ($40,080)
- 4 Planned sale President sold 6,975 shares at $20.09 ($140,128)
- 4 Other acquisition Chief Executive Officer acquired 448 shares (code W)
- 4 Planned sale Chief Operating Officer sold 21,521 shares at $17.76 ($382,213)
- 4 Returned to the company Chief Accounting Officer returned 68 shares (to the company)
- 4 Returned to the company General Counsel returned 8,067 shares (to the company)
- 4 Returned to the company Chief Medical Officer returned 3,047 shares (to the company)
- 4 Returned to the company Chief Accounting Officer returned 1,308 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 5,557 shares (to the company)
- 4 Returned to the company Chief Operating Officer returned 22,742 shares (to the company)
- 4 Returned to the company President returned 12,387 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 27,705 shares (to the company)
- 4 Planned sale Chief Accounting Officer sold 282 shares at $14.95 ($4,216)
- 4 Planned sale Chief Operating Officer sold 21,369 shares at $19.99 ($427,166)
- 4 Returned to the company Chief Medical Officer returned 3,708 shares (to the company)
- 4 Returned to the company Chief Operating Officer returned 12,506 shares (to the company)
- 4 Planned sale Chief Operating Officer sold 45,000 shares at $20.25 ($911,250)
- 4 Planned sale Chief Accounting Officer sold 1,018 shares at $20.41 ($20,777)
Page 6 of 15 · 290 filings